286 related articles for article (PubMed ID: 17323590)
1. Review of fondaparinux sodium injection for the prevention of venous thromboembolism in patients undergoing surgery.
Bergqvist D
Vasc Health Risk Manag; 2006; 2(4):365-70. PubMed ID: 17323590
[TBL] [Abstract][Full Text] [Related]
2. Fondaparinux for prevention of venous thromboembolism in major orthopedic surgery.
Tran AH; Lee G
Ann Pharmacother; 2003 Nov; 37(11):1632-43. PubMed ID: 14565815
[TBL] [Abstract][Full Text] [Related]
3. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.
Turpie AG; Bauer KA; Eriksson BI; Lassen MR
Arch Intern Med; 2002 Sep; 162(16):1833-40. PubMed ID: 12196081
[TBL] [Abstract][Full Text] [Related]
4. Fondaparinux sodium: a review of its use in the prevention of venous thromboembolism following major orthopaedic surgery.
Reynolds NA; Perry CM; Scott LJ
Drugs; 2004; 64(14):1575-96. PubMed ID: 15233593
[TBL] [Abstract][Full Text] [Related]
5. Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism.
Bauer KA; Eriksson BI; Lassen MR; Turpie AG
Curr Opin Pulm Med; 2002 Sep; 8(5):398-404. PubMed ID: 12172443
[TBL] [Abstract][Full Text] [Related]
6. Pentasaccharides in the prophylaxis and treatment of venous thromboembolism: a systematic review.
Nijkeuter M; Huisman MV
Curr Opin Pulm Med; 2004 Sep; 10(5):338-44. PubMed ID: 15316429
[TBL] [Abstract][Full Text] [Related]
7. A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: use in patients undergoing major orthopaedic surgery.
Sullivan SD; Davidson BL; Kahn SR; Muntz JE; Oster G; Raskob G
Pharmacoeconomics; 2004; 22(9):605-20. PubMed ID: 15209529
[TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against thromboembolism following major orthopedic surgery.
Gordois A; Posnett J; Borris L; Bossuyt P; Jönsson B; Levy E; de Pouvourville G
J Thromb Haemost; 2003 Oct; 1(10):2167-74. PubMed ID: 14521600
[TBL] [Abstract][Full Text] [Related]
9. Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy.
Turpie AG
Expert Opin Pharmacother; 2004 Jun; 5(6):1373-84. PubMed ID: 15163281
[TBL] [Abstract][Full Text] [Related]
10. Cost consequence analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery in Belgium.
Annemans L; Minjoulat-Rey MC; De Knock M; Vranckx K; Czarka M; Gabriel S; Haentjens P
Acta Clin Belg; 2004; 59(6):346-57. PubMed ID: 15819379
[TBL] [Abstract][Full Text] [Related]
11. Fondaparinux, the first selective factor Xa inhibitor.
Turpie AG; Eriksson BI; Lassen MR; Bauer KA
Curr Opin Hematol; 2003 Sep; 10(5):327-32. PubMed ID: 12913785
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against venous thromboembolism in patients undergoing hip fracture surgery.
Sullivan SD; Kwong L; Nutescu E
Value Health; 2006; 9(2):68-76. PubMed ID: 16626410
[TBL] [Abstract][Full Text] [Related]
13. [Standards and perspectives for thromboembolism prophylaxis].
Rader CP
Orthopade; 2007 Jun; 36(6):560, 562-6. PubMed ID: 17546440
[TBL] [Abstract][Full Text] [Related]
14. Fondaparinux sodium compared with enoxaparin sodium: a cost-effectiveness analysis.
Bjorvatn A; Kristiansen F
Am J Cardiovasc Drugs; 2005; 5(2):121-30. PubMed ID: 15725043
[TBL] [Abstract][Full Text] [Related]
15. Pharmacoeconomic analysis of fondaparinux versus enoxaparin for the prevention of thromboembolic events in orthopedic surgery patients.
Dranitsaris G; Kahn SR; Stumpo C; Paton TW; Martineau J; Smith R; Ginsberg JS;
Am J Cardiovasc Drugs; 2004; 4(5):325-33. PubMed ID: 15449974
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery.
Turpie AG; Eriksson BI; Lassen MR; Bauer KA
J South Orthop Assoc; 2002; 11(4):182-8. PubMed ID: 12597061
[TBL] [Abstract][Full Text] [Related]
17. Emerging options for thromboprophylaxis after orthopedic surgery: a review of clinical data.
Lobo BL
Pharmacotherapy; 2004 Jul; 24(7 Pt 2):66S-72S. PubMed ID: 15317401
[TBL] [Abstract][Full Text] [Related]
18. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery.
Agnelli G; Bergqvist D; Cohen AT; Gallus AS; Gent M;
Br J Surg; 2005 Oct; 92(10):1212-20. PubMed ID: 16175516
[TBL] [Abstract][Full Text] [Related]
19. Fondaparinux: basic properties and efficacy and safety in venous thromboembolism prophylaxis.
Bauer KA
Am J Orthop (Belle Mead NJ); 2002 Nov; 31(11 Suppl):4-10. PubMed ID: 12463577
[TBL] [Abstract][Full Text] [Related]
20. Perioperative bridging with fondaparinux in a woman with antithrombin deficiency.
Bauersachs R; Alban S
Thromb Haemost; 2007 Mar; 97(3):498-9. PubMed ID: 17334522
[No Abstract] [Full Text] [Related]
[Next] [New Search]
